A detailed history of Forefront Wealth Partners, LLC transactions in Geron Corp stock. As of the latest transaction made, Forefront Wealth Partners, LLC holds 52,258 shares of GERN stock, worth $58,528. This represents 0.02% of its overall portfolio holdings.

Number of Shares
52,258
Holding current value
$58,528
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$1.1 - $1.47 $57,483 - $76,819
52,258 New
52,258 $71.6 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Forefront Wealth Partners, LLC Portfolio

Follow Forefront Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Wealth Partners, LLC with notifications on news.